Hoonbae Jeon, M.D. Curriculum Vitae Hoonbae Jeon, M.D., F.A.C.S. Professor of Surgery Tulane University
Office Address: Office Telephone and FAX Department of Surgery (504)988 0783 phone 1415 Tulane Avenue #HC-5 (504)988 7510 fax New Orleans, LA 70112-2632 Email : [email protected]
EDUCATION
03/01/1983-02/ Premedical Course, College of Natural Science 28/ 1985 Korea University, Seoul, Korea
03.01.1985-02.2 M.D. College of Medicine 8.1990 Korea University, Seoul, Korea
03.01.1991-02.2 Ph.D. Graduate School 8.1995 Korea University, Seoul, Korea
POSTGRADUATE TRAINING 03.01.1990-02.2 Rotating Intern Korea University Medical Center, 8.1991 Korea University, Seoul, Korea
03.01.1991-02.2 Resident General Surgery 8.1995 Korea University Medical Center Korea University, Seoul, Korea
03.01.1996-02.2 Fellow Division of Hepatobiliary & Pancreatic Surgery 8.1998 Department of Surgery Asan Medical Center, University of Ulsan, Seoul, Korea
07.01.2000-06.3 Fellow Abdominal Organ Transplantation 0.2001 Recanati/Miller Transplant Institute Mount Sinai Medical Center, Mount Sinai School of Medicine, New York University New York, New York
07.01.2001-06.3 Fellow Abdominal Organ Transplantation 0.2003
Page 1/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae Albert Einstein Medical Center, Jefferson Medical College, Thomas Jefferson University Philadelphia, Pennsylvania
LICENSURE AND CERTIFICATIONS 03.1990 - present National Medial Licensure of Korea (No. 40402) Ministry of Health and Welfare, Republic of Korea
03. 1995 - present Foreign Board Certified in General Surgery (No.3463) by Korean Surgical Society and Ministry of Health and Welfare, Republic of Korea
10. 1997 (Indefinitely valid) ECFMG Certificate (No. 0-439-076-1)
11. 2002 USMLE step III
2000 - 2002 New York – currently inactive
2001 - 2003 Pennsylvania – currently inactive
06.2003 ASTS Certification of Transplant Fellowship
09.2003 – 02.2011 Kentucky (No. 38247) – currently inactive
01.2009 - present Illinois (No. 336.083973) - active
03.2010 – 02.2017 Primary liver / living donor liver transplant surgeon at University of Illinois Hospital (ILUI) registered to UNOS
09.2012 ASTS Leadership Development Program Kellogg School of Management Northwestern University
09.2013-04.2014 Teaching Excellence Faculty Fellowship Department of Medical Education, College of Medicine, University of Illinois at Chicago
02.2017 Louisiana (304568) - active
Page 2/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae HOSPITAL PREVILLEGE 03.20 17 – present Tulane University Medical Center New Orleans, LA
5. 2009 – 2.2017 University of Illinois Hospital at Chicago Chicago, IL
12. 2009 – 9.2013 Mount Sinai Medical Center Chicago, IL
9. 2003 – 4.2009 Albert B. Chandler Medical Center, University of Kentucky Lexington, KY
PRESENT POSITION 3. 2017 – pr e sent Professor of Surgery Department of Surgery Tulane University School of Medicine New Orleans, LA
3. 2017 – present Surgical Director, Liver Tulane University Medical Center Transplant Program New Orleans, LA
5. 2007 - present Adjunct Professor of Department of Surgery Surgery Korea University College of Medicine Seoul, Korea
PREVIOUS POSITIONS 5. 2009 – 2. 20 17 Associate Professor of Surgery University of Illinois at Chicago College of Medicine Chicago, Illinois
5. 2009 – 2. 2017 Surgical Director, Liver University of Illinois Hospital Transplant Program Chicago, Illinois
5. 2009 – 2. 2017 Director, Transplant Surgery University of Illinois at Fellowship Program Chicago College of Medicine Chicago, Illinois (Previous Trainees: Chandra Bhati, MD Atul Nanda, MD Arshad Khan, MD) 09.22.2003 Assistant Professor of Department of Surgery - 04.30.2009 Surgery University of Kentucky College of Medicine, Lexington, Kentucky
Page 3/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 09.22.2003 Transplant Surgeon University of Kentucky Transplant - 04.30.2009 Center Albert B. Chandler Medical Center Lexington, Kentucky
07.01.2001 Clinical Instructor Department of Surgery -06.30. 2003 Albert Einstein Medical Center Jefferson Medical College, Thomas Jefferson University Philadelphia, Pennsylvania
03.01 2000 Assistant Professor of Department of Surgery -6.30. 2000 Surgery Soonchunhyang University College of Medicine Seoul, Korea
03.01.1998 Instructor in Surgery Department of Surgery -02.28.2000 Soonchunhyang University College of Medicine Seoul, Korea
03.01.1998 Attending Hepatobiliary Soonchunhyang University Hospital -06.30.2000 Surgeon Seoul, Korea
03.01.1998 Surgical Consultant International Clinic, Soonchunhyang -06.30.2000 University Hospital, Seoul, Korea (A primary care facility for foreign nationals in Seoul, Korea)
03.01.1995 Clinical Instructor in Korea University College of Medicine -02.28.1996 Surgery Seoul, Korea
AWARD AND HONORS 05.2013 The Maurice F. Rabb, MD/Jose F. Pulido, MD Award (Teaching award selected by class of 2013) College of Medicine, University of Illinois at Chicago 12. 2008 Faculty teaching award, Department of Surgery, College of Medicine, University of Kentucky 10.1999– German Academic Exchange Service Scholar (Deutche Akademischer Austausch 11.1999 Dienst: DAAD) Department of Transplantation, Goettingen University - Professor Dr. med. Burckhard Ringe
PROFESSIONAL MEMBERSHIPS 2012 – present American Hepatopancreatobiliary Association
Page 4/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 2010 – present Clinical Robotic Surgery Association 2009 – present Illinois Medical Association 2009 - present Warren H. Cole Society 2007 – present Fellow, American College of Surgeons 2006 – present American Association for Study of Liver Disease 2004 - present Fellow, International College of Surgery 2003 - present American Society of Transplant Surgeons 1999 - present International Liver Transplantation Society 1997 - present Asian Society of Hepatobiliary and Pancreatic Surgery 1995 - present Korean Surgical Society 1990 - present Korean Medical Association
COMMITTEES
ACTIVE 06.2012 – present Membership Committee, American Society of Transplant Surgeons
06.2012 - present International Relation Committee, American Hepatopancreatobiliary Association
03.2017 – present Chairperson, Liver transplantation patient review committee, Tulane University Medical Center, New Orleans 03.2017 – present Kidney and pancreas transplantation patient review committee, Tulane University Medical Center, New Orleans 07.2017 - present Excecutive Board, Louisiana Organ Procurement Agency, Metarie, Louisiana
PAST 07.2016 – 02.2017 Associate councilor/Councilor elect, UNOS Region 7 (2016 – 2019) Membership and professional standard committee, UNOS/OPTN 10.2013-02.2017 Curriculum Committee, College of Medicine, University of Illinois at Chicago
09.2013-02.2017 Co-director, Combined Radiology-Surgery-Anatomy course for 4th year m edical students, College of Medicine, University of Illinois at Chicago (A new course which was launched in early 2015)
Page 5/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 05.2013 – 02.2017 Liver Transplantation Subcommittee, Gift of Hope Organ and Tissue Donor Network, Itasca, IL 05.2011 – 02.2017 Transfusion Practice Committee, University of Illinois Hospital, Chicago
02. 2010 – 02.2017 Chairperson, Kidney organ procurement and distribution committee, Gift of Hope Organ and Tissue Donor Network, Itasca, IL 08.2009 – 02.2017 Resident and Award Committee, Department of Surgery, College of Medicine, University of Illinois at Chicago 07.2009 – 02.2017 Liver Transplantation Review Board, UNOS Region 7
02.2013 – 08.2013 Search Committee for Division Chief of Gastroenterology, College of Medicine, University of Illinois at Chicago 12.2011 – 02.2013 Hospital Throughput Committee, University of Illinois Hospital, Chicago
11. 2009 – 06.2011 Chairperson, Donation after cardiac death task force, Gift of Hope Organ and Tissue Donor Network, Itasca, IL 10.2009 – 06.2011 QA Committee, Department of Surgery, College of Medicine, University of Illinois at Chicago 06.2008 – 05.2012 Winter Symposium Planning Committee, American Society of Transplant Surgeons 06.2008 – 05.2011 Vanguard Committee, American Society of Transplant Surgeons
03. 2008 - 04.2009 Task force for end-stage liver disease service, University of Kentucky College of Medicine, Lexington, KY 01.2008 – 01.2011 Continuous Medical Education Committee, International College of Surgeons 09. 2003 - 04. 2009 Kidney and Pancreas Transplant Evaluation Committee, University of Kentucky College of Medicine, Lexington, KY 09. 2003 – 04. 2009 Liver Transplant Evaluation Committee, University of Kentucky College of Medicine, Lexington, KY 09. 2003 – 03. 2007 Transplantation Steering Committee University of Kentucky College of Medicine, Lexington, KY 11.1999 - 6.2000 Organ Transplantation Committee, Soonchunhyang University College of Medicine, Seoul, Korea 9.1999 - 6.2000 Task Force for Faculty Evaluation Standard Development, Soonchunhyang University College of Medicine, Seoul, Korea
Page 6/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 8.1998 - 6.2000 Co-Chair, Hospital Nutrition Committee, Soonchunhyang University College of Medicine, Seoul, Korea 11.1998 - 6.2000 Residency Program Review Committee, Korean Surgical Society
11. 1996 - 10. 1998 Editorial Committee, Korean Surgical Society
3.1994 - 2.1995 Chairperson, Committee of Chief Residents, Korea University College of Medicine, Seoul, Korea
EDITORIAL ACTIVITIES 08.2016 – present Editor, Korean Journal of Hepatobiliary and pancreas surgery 01.2016 – present Peer Reviewer, World Journal of Surgery 05.2014 – present Peer Reviewer, JAMA Surgery 01.2013 – present Peer Reviewer, Transplantation
01.2012 – present Peer Reviewer, Mount Sinai Journal of Medicine 12.2011 – present Peer Reviewer, International Journal of Gastrointestinal Cancer 03.2011 – 04.2014 Associate Editor, BMC Gastroenterology 07.2010 – present Peer reviewer, American Journal of Surgery 10.2008 – 10.2011 Abstract Reviewer, Winter Symposium, American Society of Transplant Surgeons 09. 2006 – present Peer reviewer, Liver Transplantation 11.1996 - 9.1998 Assistant Editor, Journal of Korean Surgical Society
RESEARCH
Previous Projects 1. Co-Investigator, (PI: West-Thielke, P) A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients. Sponsor: Astellas, 2012- 2017, Amount: $380,000 2. Co-Investigator, (PI: West-Thielke, P) A Randomized, Open-label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy Study Number: C10-001. Sponsor: Alexion, 2012-2017, Amount: $268,000
Page 7/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 3. Co-Investigator, (PI: West-Thielke, P) LCP-Tacro 3003 Switching Study of Kidney Transplant Patients with Tremor to LCP-TacrO (STRATO). Sponsor: Veloxis, 2011-2017, Amount: $48,000 4. Co-Investigator, (PI: West-Thielke, P) Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation. Sponsor: Quark, 2008-2017, Amount: $27,000 5. Co-Investigator, (PI: West-Thielke, P) A Phase 2, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Pharmacokinetics of LCP Tacro (TM) Tablets, Once Daily, Compared to Prograf(R) Capsules, Twice Daily, for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients. Sponsor: Veloxis, 2012-2013, Amount: $87,000. 6. Co-Investigator, (PI: West-Thielke, P) A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Efficacy and Safety of LCP Tacro ™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients. Sponssor: Veloxis, 2011-2013, Amount: $170,000 7. Co-Investigator, (PI: West-Thielke, P) A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Safety and Tolerability Study of ASKP1240 in de Novo Kidney Transplantation. Sponsor: Astellas, 2009-2011, Amount: $43,000 8. Co-Investigator (PI: Oberholzer, J), 12 month, multi-center, randomized, open-label non-inferiority study comparing the safety and efficacy of concentration-controlled Everolimus with low dose tacrolimus to CellCept® (mycophenolate mofetil) with standard dose tacrolimus in de novo renal transplant recipients. Sponsor: Novartis, 2008-2010, Amount: $181,000 9. Co-Investigator, The Effects of Thymoglobulin on Immune Cell Function, 2010-2015 10. Co-Investigator, Determination of the effects of thymoglobulin dose adjustments on renal transplant outcomes, 2011-2015 11. Co-Investigator, A Comparison of Alemtuzumab and Antithymocyte Globulin Induction in High-Risk , Non-Sensitized Renal Transplant Recipients, 2013-2017 12. Co-Investigator, Limited Access Protocol for the Use of Oral Cisapride in the Treatment of Refractory Gastroesophageal Reflux Disease and Other Gastrointestinal Motility Disorder - CIS-USA-154, 2012-2017 13. Co-Investigator, Abdominal Organ Preservation with Normothermic Recirculation in Potential Donors Expiring After Out-or-Hospital Cardiac Arrest, 2012-2017 14. Co-Investigator, Simultaneous Robotic Kidney Transplantation and Bariatric Surgery for Morbidly Obese Patients with End-Stage Renal Failure, 2012-2017 15. Co-Investigator, LCP-Tacro 3003 Switching Study of Kidney Transplant Patients with Tremor to LCP-TacrO (STRATO), 2012-2017 16. Co-Investigator, Racial Profile of Live Kidney Donations at UICMC from January 1, 2007 to May 31, 2012, 2012-2017 17. Co-Investigator, Evaluating Nulojix Long Term Safety in Transplant (ENLiST), 2012-2017 18. Co-Investigator, Retrospective/Prospective Study of Kidney Transplant Outcomes 1968 through Present, 2012-2017 19. Co-Investigator (PI: Oberholzer, J) “Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression. Protocol No. 2004-0532, 2009 - 2017
Page 8/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 20. Co-Investigator (PI: Oberholzer, J) “Islet Transplantation in Type 1 Diabetic Patients Using the UIC Protocol Phase 3 “Protocol No. 2007-0330, 2009 - 2017 21. Co-Investigator (PI: Tzvetanov, I) “Retrospective/Prospective Study of Small Bowel Transplant Outcomes” Protocol No. 2008-0070, 2009 - 2017 22. Primary Investigator “Retrospective/Prospective Study of Liver Transplant Outcomes January 1985 through Present” Protocol No.2008-0072, 2009 - 2017 23. Co-Investigator (PI: Oberholzer, J) Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients: Efficacy of Islet after Kidney Transplantation” Protocol No. 2008-0175, 2009 - 2017 24. Co-Investigator (PI: West-Thielke, P) Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation” Protocol No. 2008-1085, 2009 - 2017 25. Co-Investigator (PI: West-Thielke, J) Levofloxacin Prophylaxis for BK Viremia in Kidney Transplant Recipients” Protocol No. 2009-0019, 2009 - 2017 26. PI – Patricia West Thielke, Co-Investigator (PI: West-Thielke, P) A Collaborative Experience Using Bortezomib for the Treatment of Antibody Mediated Rejection in Solid Organ Transplantation” Protocol No. 2009-1213, 2009 – 2017 27. Co-Investigator (PI: West-Thielke, P) Analysis of Risk Factors for Long Term Outcomes of Kidney and/or SPK Transplant Recipients (OPTN)” Protocol No. 2010-0202, 2009 - 2017 28. Co-Investigator (PI: West-Thielke, P) Pancreas Transplant Outcomes: A Single Center Experience with Steroid Avoidance” Protocol No. 2010-0821, 2010 - 2017 29. Co-Investigator (PI: West-Thielke, P) A Randomized, Open-label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy Study Number: C10-001” Protocol No. 2011-0510, 2011 - 2017 30. Co-Investigator (PI: Benedetti, E) Randomized Case-Control Trial About the Impact of Targeted Physical Activity and Diet Modification on Obese Kidney Transplant Recipients' Outcome” Protocol No. 2011-0808, 2011 - 2017 31. Co-Investigator (Giulianotti, PC) Retrospective Study of Robotic Surgery Outcomes” Protocol No. 2011-1104, 2011 - 2017 32. Co-Investigator (PI: West-Thielke, P) LCP-Tacro 3003 Switching Study of Kidney Transplant Patients with Tremor to LCP-TacrO (STRATO)” Protocol No. 2012-0099, 2012 - 2017 33. Co-Investigator (PI: Oberholzer, J) Extended Follow Up after Islet Transplantation in Type I Diabetes, CIT-08” Protocol No. 2012-0834, 2012 - 2017 34. Co-Investigator (PI: West-Thielke, P) A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients” Protocol No. 2012-1116, 2012 - 2017t 35. Co-Investigator (PI: Oberholzer, J)” A 12-month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing the Safety and Efficacy of Concentration-controlled Everolimus with Low Dose Tacrolimus to CellCept (Mycophenolate Mofetil) with Standard Dose Tacrolimus in de Novo Renal Transplant Patients” Protocol No. 2010-0309, 2010 - 2012 36. Co-Investigator (PI: West-Thielke, P) A 12-month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing the Safety and Efficacy of Concentration-controlled Everolimus with Low Dose Tacrolimus to CellCept (Mycophenolate Mofetil) with Standard Dose Tacrolimus in de Novo Renal Transplant Patients 2010
Page 9/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 37. Co-Investigator (PI: West-Thielke, P) A Phase 1b, Randomized , Double-Blind, Parallel Group, Placebo- Controlled, Single-Dose , Pharmacokinetic, Safety and Tolerability Study of ASKP 1240 in de Novo Kidney Transplantation 2010 38. Primary Investigator Efficacy of neoadjuvant chemo radiotherapy followed by liver transplantation for hilar cholangiocarcinoma; a multi-center review 2010 39. Co-Investigator (PI: Oberholzer, J) Extended Follow Up After Islet Transplantation in Type 1 Diabetes, CIT-08 2011 40. Co-Investigator (PI: West-Thielke, P)” A Phase 2, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Pharmacokinetics of LCP Tacro (TM) Tablets, Once Daily, Compared to Prograf(R) Capsules, Twice Daily, for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients” Protocol No. 2012-0974 41. Co-Investigator (PI: West-Thielke, P)” The Effects of Thymoglobulin on Immune Cell Function” Protocol No. 2010-1013 42. Co-Investigator (PI: West-Thielke, P)” A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Efficacy and Safety of LCP-Tacro Tablets, Once Daily, Compared to Prograf Capsules, Twice Daily, in Combination with Mycophenolate Mofetil for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients” Protocol No. 2011-0112 43. Co-Investigator (PI: Oberholzer, J)” A52 Week Randomised, Double-Blind, Placebo Controlled, Parallel Group, Multi-Centre, Multinational Exploratory Trial in Islet Cell Transplant Subjects With Type 1 Diabetes Mellitus to Evaluate The Early Use of Liraglutide As An Adjunct to Standard Care Regarding the Percentage of Subjects Achieving Insulin Independence After First Transplantation. Trial ID: NN2211-3619” Protocol No. 2011-1122 44. Primary Investigator “CellCept (mycophenolate mofetil) maintenance immunosuppression in liver transplant recipients with long-term follow-up posttransplantation of non-autoimmune lie r disease – A prospective, randomized, multicenter trial.”. Sponsor: Roche/Albert Einstein Medical Center. $ 37,298.74 Protocol No. CEL350, IRB 060892F1V 45. Co-Investigator (PI: Ranjan D) “A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir versus Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants.” Sponsor: ViroPharma. $ 116,495, 07-0541-F6A 46. Co-Investigator (PI: Ranjan D) “A Randomized, Open- Label, Comparative Evaluation of Conversion from Calineurin Inhibitor Treatment Versus Continued Calineurin Inhibitor Treatment in Liver Allograft Recipients Undergoing Maintenance Therapy”. Sponsor: Wyeth Research. $263,193, 2002- Protocol 0468H1-316-US 47. Co-Investigator (PI: Johnston TD) “A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long-Term Maintenance Corticosteroid Therapy with Zenapax, Prograf, and CellCept in Primary Renal Transplant Recipients.” Sponsor: Fujisawa Healthcare Incorporated Funding: $120,000 (projected) 6 subjects enrolled. Protocol Number 20-99-001. 48. Co-Investigator (PI: Johnston TD) “A 24-Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Concentration-Controlled Certican® in Two Doses (1.5 and 3.0 mg/day Starting Doses) with Reduced Neoral® versus 1.44 Myfortic® with Standard Dose Neoral in de novo Renal Transplant Recipients (2309)” Sponsor: Novartis $ 339,206.63, 05-0639-F1V
Page 10/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 49. Co-Investigator (PI: Johnston TD) “A Facilitated Access Program to Provide Everolimus (RAD) for Maintenance Patients Completing Therapy in RAD Trials in Solid Organ Transplantation (2401)” Sponsor: Novartis $ 25,010, 76 07-0892-F6A 50. Co-Investigator (PI: Johnston TD) “Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (IM103-008)” Sponsor: BMS $ 253,525, 06-0436-F1V 51. Co-Investigator (PI: Johnston TD) “A Randomized, Open-Label, Multicenter, Parallel-Group Study of Belatacept-Based Corticosteroid-Free Regimens in Renal Transplant (IM103-034)” Sponsor: BMS $ 67,264 07-0661-F6A 52. Co-Investigator (PI: Johnston TD) “A 24-Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Concentration-Controlled Certican® in Two Doses (1.5 and 3.0 mg/day Starting Doses) with Reduced Neoral® versus 1.44 Myfortic® with Standard Dose Neoral in de novo Renal Transplant Recipients (2309)” Sponsor: Novartis $ 339,206.63 05-0639-F1V 53. Co-Investigator (PI: Johnston TD) “A Randomized, Open-label, Study to Compare the Safety and Efficacy of Two Different Rapamune Regimens With A Tacrolimus+ Mycopheonlate Mofetil Regimen In De Novo Renal Allograft Recipients (ORION)” Sponsor: Wyeth $ 124,308 04-0387-F2L 54. Co-Investigator (PI: Johnston TD) “A Randomized, Open-Label, Comparative Evaluation of Conversion from Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients (316)” Sponsor: Wyeth $ 225,900 03-0054-F3R 55. Primary Investigator “A Prospective, Randomized, Open-Label, Twenty-Six Week Study of the Efficacy and Safety of Converting Liver Transplant Recipients with Tacrolimus-Associated Abnormal Glucose Metabolism to Neoral with C2 Monitoring.” . Novartis Pharmaceuticals Corporation, 2003 Funding: $75,000 Projected enrollment: 10 Site initiated: 1/30/04 Currently enrolled: 2, Closed Protocol COLO 400A US 06 56. Co-Investigator. (PI: Sheiner P.) A Randomized, Open-Label Preference Study of Gengraf™ Compared to Neoral® in Stable Solid-Organ Transplant Subjects. GCO# 00-0454.Abbott Laboratories, $75,000.00 7/2000-6/2001 57. Co-Investigator (PI:Fishbein T.) A Randomized, Comparative Trial of Prograf (Tacrolimus) in Combination with Sirolimus or Mycophenolate Mofetil after Liver Transplantation. GCO# 00-0451.Fujisawa Health Care Inc. $80,000.00. 7/2000-6/2001 58. Co-Investigator (PI:Sheiner P.) A Prospective, Randomized, Multicenter, Open-Label, Comparative Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys®) Plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C. National Institutes of Health. GCO # 99-1022. $352,464.00. 7/2000-6/2001 59. Co-Investigator (PI:Sheiner P.) Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5%, Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination with Lamivudine for Patients with Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation” Gco # 99-1005.Mayo Clinic. Total Grant $6,000.00 7/2000-6/2001 60. Co-Investigator (PI:Sheiner P.) The Pharmacokinetics and Safety of Boca HBVIg Given Intravenously to Patients Following Orthotopic Liver Transplantation for Chronic Hepatitis B. Nabi Pharmaceuticals. GCO # 99-0852.Total Grant: $57,600.00 7/2000-6/2001
Page 11/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 61. Co-Investigator (PI:Burrows L.)Prograf (tacrolimus) as Secondary Intervention vs. Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure. GCO# 99-0115. Fujisawa Health Care Inc. $18,000.00 7/2000-6/2001 62. Co-Investigator (PI: Bromberg J.)Multicenter, randomized, partially-blinded study of the safety and efficacy of FTY 720 combined with corticosteroids and full or reduced-dose Neoral in de novo adult renal transplant recipients. GCO# 00-0132 Novartis Pharmaceuticals: $ 85,000.00 7/2000-2/2001 63. Co-Investigator (PI: Emre S.) A multi-center, randomized, double-blind, parallel group, placebo-controlled dose exploratory trial evaluating the safety and effect of activated ® recombinant factor VIIa (rFVIIa/ NovoSeven ) in the prevention of bleeding in subjects undergoing orthotopic liver transplantation. GCO# 00-0002.NovoNordisk Pharmaceuticals. $ 200,000.00 7/2000-4/2001 64. Co-Investigator (PI: Bromberg J.) “A 1-Year, Multicenter, Single Arm, Open Label, Pilot Study of the Efficacy and Safety of RAD in de novo Renal Transplant Recipients At Immunological High Risk of Rejection”. GCO# 00-0181.Novartis Pharmaceuticals. $58,000.00 7/2000-6/2001 65. Co-Investigator. (PI: Sheiner P.) A Randomized, Open-Label Preference Study of Gengraf™ Compared to Neoral® in Stable Solid-Organ Transplant Subjects. GCO# 00-0454.Abbott Laboratories, $15,000.00 7/2000-6/2001 66. Co-Investigator (PI:Fishbein T.) A Randomized, Comparative Trial of Prograf (Tacrolimus) in Combination with Sirolimus or Mycophenolate Mofetil after Liver Transplantation. GCO# 00-0451.Fujisawa Health Care Inc. $80,000.00. 7/2000-6/2001 67. Co-Investigator (PI:Bromberg J.) Open-label, randomized, controlled multiple-dose study of efficacy and safety of BMS-224818 as part of a quadruple drug regimen in first renal transplant recipients. GCO# 00-1105. Bristol-Myers Squibb Pharmaceuticals: $245,000.00 7/2000-6/2001 68. Co-Investigator (PI: Emre S.) An Ascending, Single Dose, Safety, Tolerance, and Pharmacokinetic Study of Oral Sirolimus Solution (Rapamune) in Pediatric Patients with Stable Liver Allografts Receiving Daily Oral Doses of Tacrolimus. GCO# 00-0827.Wyeth Ayerst Pharmaceuticals. $153,350.00. 7/2000-6/2001 69. Co-Investigator (PI: Waid T) “A Phase II, Randomized, Multi-Center, Open-Label Safety Study of ISATX247 and Cyclosporine (Neoral) in Post-Renal Transplant Patients.” Sponsor: Isotechnika Incorporated, 2002. 2 subjects enrolled Funding: $35,433 Protocol ISA00-16. 8/2002-8/2004 70. Co-Investigator (PI: McKeown JW) “Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring versus Tacrolimus” Protocol Number OLO400A2419 Sponsor: Novartis Funding: $152,864.05 Patients Enrolled/Projected: 7/10 Open Date: 4/1/04 Closed 71. Co- Investigator (PI: Waid T) A Randomized, Open-Label Study to Compare the Safety and Efficacy of Two Different Rapamune Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients. Sponsor: Wyeth Funding: $124,676.79 Patients Enrolled/Projected: 4/10 Open Date: 9-2-04 Closed Protocol Number 0468H1-101497 72. Co-Investigator (PI: Waid TD) “Prograf (tacrolimus) as Secondary Intervention vs. Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure.” Sponsor: Fujisawa Healthcare, Incorporated Funding: $138,425 32 subjects enrolled Open date: 5/3/99 (IRB approval) Closure date: 9/2005 (projected) Protocol 20-98-002.
Page 12/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 73. Co-Investigator (PI: Johnston TD) “A Phase III, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (cyclosporine)/MMF in de novo Kidney Transplant Recipients.” Sponsor: Fujisawa Healthcare, Incorporated Funding: $292,890 10 subjects projected, 3 subjects enrolled Open date: 8/18/03 (IRB approval) Closure date: 8/2007 (projected) Protocol 02-0-158. 74. Co Investigator (PI: Johnston TD) An Open Label, Randomized, Multicenter Study To Evaluate The Efficacy and Safety of Early Calcineurin Inhibitor Withdrawal In Recipients Of Primary Renal Allografts Maintained Long-Term On Mycophenolate Mofetil and Sirolimus. Sponsor: Roche Laboratories. 2003- -$118,150 Protocol ML17140/01265 75. Co- Investigator (PI: West-Thielke, P) A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in de novo Kidney Transplant Recipients. 2008 (Protocol 2008-0002) 76. Co- Investigator (PI: West-Thielke, P) A Phase 3, Open-Label, Multicenter, Prospective, Randomized Study of the Efficacy and Safety of Conversion From Prograf Capsules Twice Daily to LCP-TACRO Tablets Once Daily for the Prevention of Acute Allograft Rejection in Stable Kidney Transplant Patients (Protocol 2008-1091) 77. Co- Investigator (PI: West-Thielke, P) A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Safety and Tolerability Study of ASKP1240 in de Novo Kidney Transplantation (Protocol 2010-0702)
MANUSCRIPTS PUBLISHED IN PEER-REVIEWED JOURNALS 1. Jeon H, Choi SY, Kim YC, Koo B: An Experimental study on the enhanced cytolytic effects of Natural Killer Cells by interleukin-2. Journal of Korean Surgical Society vol.45 no.3 pp.313-324. 1993 2. Jung SI, Jeon H, Lee ES, Nam YS, Hwang CW: Profundoplasty for combined aortoiliac and superficial femoral occlusive lesion. Journal of Korean Surgical Society vol.47 no.4 pp.565-573. 1994 3. Jeon H, Koo B, Chae Y: Relation between p53 overexpression and established prognostic factors in breast cancer. Journal of Korean Surgical Society vol.48 no.5 pp.648-660. 1995 4. Lee SD, Jeon H, Mok YJ, Choi SY, Moon H, Koo B: Experiences of hepatic resection after preoperative transarterial chemoembolization in hepatocellular carcinoma. Journal of Korean Surgical Society vol.50 no.3 pp.395-401. 1996 5. Kim C, Jeon H: Clinical experience of circumumbilical incision for infantile hypertrophic pyloric stenosis. Journal of Korean Association of Pediatric Surgeons vol.2 no.2. 1996 6. Lee YJ, Lee SG, Park KM, Hwang S, Nam CW, Jeon H, Lee SG, Kim MH, Min PC: Two cases of advanced mucin producing pancreatic tumor. Korean Journal of HBP Surgery vol.1 no.1 pp.155-160. 1997 7. Kim KM, Lee SG, Lee YJ, Park KM, Kim SC, Jeon H, Kwon SW, Han SH, Lee MG, Choi KT, Ha HS: Living related liver transplantation across ABO blood groups. Journal of Korean Society of Transplantation vol.11 no.1 pp.145-149. 1997 8. Kim CS, Jeon H, Ryu JW, Kim KH, Koo BH: The effect of surgical manipulation on the bacterial translocation from the gut. Journal of Korean Surgical Society vol.52 no.6 pp.790-795. 1997
Page 13/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 9. Lee YJ, Lee SG, Jeon H, Park K, Nam CW, Hwang S, Min PC: Anormalous vessels encountered during hepatoduodenal and/or aortocaval lymph node dissection. Journal of Korean Surgical Society vol.53 no.1 pp.105-110. 1997 10. Jeon H, Lee SG, Min PC: Experience of an en bloc resection of right lobe of liver, adrenal, kidney and infrahepatic vena cava with the aid of veno-venous bypass. Korean Journal of HBP Surgery vol.1 no.2 pp.171-177. 1997 11. Hwang S, Lee SG, Lee YJ, Park KM, Jeon H, Kim PN, Min PC : Calculation of standard liver volume of Korean adult. Korean Journal of HBP Surgery vol.1 no.2 pp.59-65. 1997 12. Jeon H, Cho YP, Lee SG, Lee YJ, Park KM, Choi KM, Hwang S, Min PC, Kim MH, Lee SG: Treatment of ampullary neoplasm, diagnosed as benign on preoperative endoscopic biopsy. Journal of Korean Surgical Society vol.53 no.2 pp.258-264. 1997 13. Park KM, Lee SG, Lee YJ, Jeon H, Hwang S, Choi KM, Kwon TW, Nam CW, Kim KM, Lee MG, Sung KB, Han SH, Ko KS, Choi KT, You ES, Oh WI, Kim SC, Chung YH, Lee YS, Min PC : Major complications after orthotopic liver transplantations. Journal of Korean Surgical Society vol.53 no.3 pp.415-431. 1997 14. Lee SG, Lee YJ, Park KM, Jeon H, Choi KM, Kim MH, Lee SG, Sung KB, Hwang S, Cho YP, Woo DH, Kim WY, Min PC: Fifty major liver resections for Klatskin tumor. Korean Journal of Gastroenterology vol.30 no.3 pp.369-378. 1997 15. Lee YJ, Lee SG, Park KM, Jeon H, Nam CW, Hwang S, Min PC: Changing patterns in the serum amylase level and the serum lipase level following hepatic resection with Pringle’s maneuver. Journal of Korean Surgical Society vol.53 no.5 pp.714-719. 1997 16. Hwang S, Lee SG, Park KM, Jeon H, Nam CW, Hwang S, Min PC: Significance of preoperative portal vein embolization of cirrhotic livers for major hepatectomy. Journal of Korean Surgical Society vol.53 no.5 pp.560-570. 1997 17. Kim WY, Lee SG, Lee YJ, Park KM, Jeon H, Hwang S: Clinical experiences of hepatic resection for a ruptured hepatocellular carcinoma. Journal of Korean Surgical Society vol.53 no.6 pp.395-401. 1997 18. Lee HK, Park KM, Jeon H, Lee YJ, Hwang S, Lee SG: The outcomes of curative surgery for primary duodenal malignancy. Journal of Korean Surgical Society vol.54 no.4 pp.531-535. 1997 19. Kim KM, Lee SG, Lee YJ, Park KM, Kim SC, Jeon H, Yoo ES, Ko KS, Han SH, Lee MG, Choi KT, Ko JK, Moon HN: Living related donor liver transplantation in children: Indication and clinical outcome. Journal of Korean Pediatric Society vol.41 no.5 pp.622-632. 1998 20. Lee SG, Lee YJ, Park KM, Jeon H, Hwang S, Lee KH, Lee RK, Lee JJ, Jung JH, Choi WY, Choi JW, Ahn CS, Ha TY, Jung HJ, Lee BC, Ko KH, Park SH, Choi KT, Lee YS, Chung YH, Suh DJ, Kim MH, Lee MH, Sung KB, Kim MK, Ha HS, PC Min : Adult-to-adult living donor liver transplantation. Journal of Korean Surgical Society vol.55 no.5 pp.719-725. 1998 21. Song TJ, Jeon H, Yun JS, Choi SY: Splenic metastasis of lung cancer. Journal of Korean Surgical Society vol.55 no.5 pp.775-778. 1998 22. Youm W, Yun IJ, Jeon H, Lee SY, Jung YS, Lim H, Moon C: Cavoatrial shunt for IVC obstruction by organized thrombosis. Korean Journal of Vascular Surgery vol.15 no.1 pp.153-158. 1999 23. Lee SG, Hwang S, Park KM, Jeon H, Min PC : Regeneration of graft liver in adult-to-adult living donor liver transplantation using a left lobe graft. Journal of Korean Medical Science. vol.13 no.4 pp.350-354. 1998 24. Jeon H, Lee SG, Lee YJ, Park KM, Hwang S, Kim PN, Min PC: Xanthogranulomatous cholecystitis. Korean Journal of HBP Surgery vol.3 no.2 pp.171-177. 1999
Page 14/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 25. Shim CS, Moon JH, Cho YD, Lee MS, Jeon H, Jin SY, Lee HK: Neuroendocrine Carcinoma of the ampulla of Vater. Gastrointestinal Endoscopy vol. 51 no.5 pp. 593-594. 2000 26. Shim CS, Moon JH, Cho YD, Hong SJ, Kim JO, Cho JY, Lee MS, Jeon H, Hur KY, Jin SY: Argon plasma coagulation for the endoscopic treatment of a non-resectable Klatskin tumor: In vitro and in vivo study. Digestive Endoscopy. Vol. 12 no.2 pp. 141-146. 2000 27. Jeon H, Ortiz JA, Manzarbeitia CY, Alvarez SC, Sutherland DER, Reich DJ: Combined liver and pancreas procurement from a controlled non-heart-beating donor with aberrant hepatic arterial anatomy. Transplantation vol. 74 no. 11 pp.1636-1638. 2002 28. Yoshizumi T, Gondolesi GE, Bodian CA, Jeon H, Schwartz ME, Fishbein TM, Miller CM, Emre S: A simple new formula to assess liver weight. Transplantation Proceedings. Vol. 35 no. 4 pp.1415-1420. 2003 29. Briceno PJ, Ortiz JA, Manzarbeitia CY, Jeon H, Munoz SJ, Rothstein KD, Araya VR, Gala I, Reich DJ : Liver transplantation using an organ donor With HELLP Syndrome. Transplantation vol. 77. No.1 pp. 137-139. 2004 30. Manzarbeitia CY, Ortiz JA, Jeon H, Munoz SJ, Rothstein KD, Araya VR, Reich DJ : Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation. Vol. 78 no 2. pp. 211-215. 2004 31. Johnston TD, Thacker LR, Jeon H, Lucas B, Ranjan D : Sensitivity of expanded-criteria donor kidneys to cold ischemia time. Clin Transplantation. Vol. 18:S12:28-32. 2004 32. Lopez NM, Jeon H, Ranjan D, Johnston TD: Atypical etiology of massive gastrointestinal bleeding: arterio-enteric fistula following enteric drained pancreas transplant. Am Surg vol.;70. no.6 :529-32. 2004 33. Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M: Curcumin inhibits mitogen stimulated lymphocyte proliferation, NF kappaB activation, and IL-2 signaling. J Surg Res. Vol. 121 no.2 pp.171-177.2004 34. Ranjan D, Chen C, Johnston TD, Jeon H, Ibrahim, M, Drake J, Butterfield DA : Stimulation of Epstein-Barr virus- infected human B cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funt vol. 24 no.2 pp.147-152 2005 35. Jeon H, Johnston TD, Strup SE, Ibrahim M, Ranjan D: University of Kentucky experience of laparoscopic live donor nephrectomy using two different techniques. Int Surg vol.91 no.6 pp.332-335 2006 36. Ranjan D, Schmonsky K, Johnston TD Jeon H, Bouneva I, Erway E. Financial analysis of potential donor management at a Medicare approved transplant Hospital. Am J Transplant vol. 6 no.1.pp.199-204 2006 37. Sha SH, Johnston, TD, Jeon H, Ranjan D: Effect of Chronic Glucocorticoid Therapy and the Gender Difference on Bone Mineral Density in Liver Transplant Patients. J Surg Res vol135 no.2.pp. 238-241 2006 38. McConathy K, Turner V, Johnston T, Jeon H, Bouneva I, Koch A, Clifford T, Ranjan D. Analysis of smoking patients referred for liver transplantation and its adverse impact of short-term outcomes. J Ky Med Assoc Jun: 105(6):261-6 2007 39. Clifford T, Johnston T, Jeon H, Gedaly R, Ranjan D. A Pharmacoeconomic analysis of liver transplant charges. Progress in Transplantation, Vol 17, No. 4, December 2007 40. Jeon H, McHugh P, Banerjee A, Gedaly R, Johnston T, Ranjan D. The use of Dacron graft for cavo-cavostomy in Orthotopic Liver Transplantation. Transplantation 2008 vol. 85 no. 4:651-653 41. Gedaly G, Jeon H, Johnston T, McHugh P, Rowland R, Ranjan D. Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis. World Journal of Surgical Oncology 2008, vol. 6 no. 41
Page 15/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 42. Jeon H, McHugh P, Gedaly R, Johnston T, Ranjan D, Pu L. Successful Management of Eviscerated Renal Allograft with Preservation of Function. Am J Trans 2008 vol. 8 no.5:1067-70 43. Johnston T, Jeon H, Gedaly R, Ranjan R. Importance of local infection in hepatic artery pseudoaneurysms. Liver Transplantation 2008. vol. 14 no. 3:388 44. Gedaly R, Clifford, TM, McHugh PP, Jeon H, Johnston, TD, Ranjan D. Prevalent immunosuppressive strategies in liver transplantation for hepatitis C: results of multi-center international survey. Transplant Int. 2008. May 21 45. Chen C, Johnston TD, Jeon H, Gedaly R, McHugh P, Ranjan D. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells. J Surg Res. 2008 Apr 8. 46. Jeon H, Ranjan D. The easiest way to improve the outcome of suboptimal liver graft. Liver Transplantation 2008 Jun;14(6):905; author reply 906-7 47. McHugh P, Jeon H, Gedaly R, Johnston T, DePriest P, Ranjan D. Vaginal Varices with Massive Hemorrhage in a Patient with NASH and Portal Hypertension: Successful Treatment with Liver Transplantation. Liver Transplantation 2008 Oct; 14(10):1538-40. 48. Chen C, Jeon H, Johnston, TD, Gedaly R, McHugh PP, Ranjan D. Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants. J Invest Surg. 2008 Jul-Aug; 21(4):201-8. 49. Gedaly R, McHugh PP, Johnston TD, Jeon H, Koch A, Clifford TM, Ranjan D. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation. 2008 Oct 27; 86(8):1090-5.
50. Chen C, Johnston TD, Jeon H, Gedaly, R, McHugh PP, Burke TG, Ranjan D. An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm. 2008 Sep 17. 51. McHugh PP, Johnston TD, Gedaly R, Jeon H, Ranjan D. Seatbelt injury resulting in functional loss of a transplanted kidney. Prog Transplant. 2008 Sep;18(3):199-202. 52. McHugh PP, Johnston TD, Gedaly R, Jeon H, Ranjan D. Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient. Ann Transplant. 2008 13(3): 19-22 53. Giulianotti P, Gorodner V, Sbrana F, Tzvetanov I, Jeon H, Bianco F, Kinzer K, Oberholzer J, Benedetti E. Robotic transabdominal kidney transplantation in a morbidly obese patient. Am J Transplant. 2010 10(6): 1478 – 1482 54. Jeon H, Lee SG. Living donor liver transplantation. Curr Opin Organ Transplant. 2010 15(3): 283 – 287 Review. 55. Krishnamoorthy V, Li J, Jeon H, Nicolau R. Use of an Inferior Epigastic Arterial Catheter in a Patient With Difficult Vascular Access. J Cardiothorac Vasc Anesth 2011 Jun 1. [Epub ahead of print] 56. Ghafari JL, Bhati C, John E, Tzvetanov IG, Testa G, Jeon H, Oberholzer J, Benedetti E. Long-term follow-up in adult living donors for combined liver/bowel transplant in pediatric recipients: A single center experience. Pediatr Transplant. 2011 Jun;15(4):425-9. 57. Tzvetanov IG, Bhati CS, Jeon H, Glover AE, Oberholzer J, Benedetti E. Segmental intestinal autotransplantation after extensive enterectomy for removal of large intra-abdominal desmoid tumors of the mesentery root: Initial experience. Surgery. 2011 Oct 5.
Page 16/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 58. Jeon H, Bhati C, Tzvetanov I, Oberholzer J, Kinzer K, Benedetti E. Calibrated extra-anatomic hepatic arterial reconstruction in living donor liver transplantation. Transpl Int. 2012 Jan; 25(1):e16-8. 59. Giulianotti P, Gorodner V, Sbrana F, Tzvetanov I, Jeon H, Bianco F, Kinzer K, Oberholzer J, Benedetti E. Robotic transabdominal kidney transplantation in a morbidly obese patient. Am J Transplant. 2010 Jun; 10(6):1478-82. Epub 2010 May 10. 60. Ghafari J, Tzvetanov I, Spaggiari M, Jeon H, Oberholzer J, Benedetti E. The effect of small bowel living donation on donor lipid profile. Transpl Int. 2012 Jan;25(1):e19-20. Epub 2011 Oct 11. 61. Giulianotti PC, Tzvetanov I, Jeon H, Bianco F, Spaggiari M, Oberholzer J, Benedetti E. Robot-assisted right lobe donor hepatectomy. Transpl Int. 2012 Jan; 25(1):e5-9. doi: 10.1111/j.1432-2277.2011.01373.x. Epub 2011 Oct 27. 62. Sohn AJ, Jeon H, Ahn J. Primary care of the liver transplant recipient. Prim Care. 2011 Sep; 38(3):499-514; ix. Review. 63. Tzvetanov I, Spaggiari M, Oberholzer J, Setty S, Stephenson A, Thielke J, West-Thielke P, Jeon H, Danielson KK, Kaplan B, Benedetti E. Cell population in Spleens during antibody-mediated rejection: pathologic and clinical findings. Transplantation. 2012 Aug 15; 94(3): 255-62. PubMed PMID: 22790386. 64. Tzvetanov I, Spaggiari M, Jeon H, Bhati C, Hassan S, Joseph J, Heinrich L, Thielke J, Setty S, Oberholzer J, Benedetti E. Rescue Splenectomy in a Case of Humoral Rejection in ABO-Incompatible Simultaneous Liver-Kidney Transplantation. Transplantation. 2012 Jan 27; 93(2):e1-2. 65. Tzvetanov I, Spaggiari M, Jeon H, Roca RG, Bhati C, Oberholzer J, Benedetti E. The role of splenectomy in the setting of refractory humoral rejection after kidney transplantation. Transplant Proc. 2012 Jun; 44(5):1254-8. PubMed PMID: 22663995. 66. Wang Y, Mendoza-Elias JE, Qi M, Harvat TA, Ahn SJ, Lee D, Gutierrez D, Jeon H, Paushter D, Oberholzer J. Implication of mitochondrial cytoprotection in human islet isolation and transplantation. Biochem Res Int. 2012; 2012:395974. Epub 2012 May 7. PubMed PMID: 22611495: PubMed Central PMCID: PMC3352213. 67. Lo JF, Wang Y, Blake A, Yu G, Harvat TA, Jeon H, Oberholzer J, Eddington DT. Islet precondition via multimodal microfluidic modulation of intermittent hypoxia. Anal Chem. 2012 Feb 21; 84(4):1987-93. Epub 2012 Feb1. PubMed PMID: 22296179; PubMed Central PMCID: PMC3302975. 68. Wang Y, Lee D, Zhang L, Jeon H, Mendoza-Elias JE, Harvat TA, Hassan SZ, Zhou A, Eddington DT, Oberholzer J. Systematic prevention of bubble formation and accumulation for long-term culture of pancreatic islet cells in microfluidic device. Biomed Microdevices. 2012 Apr; 14(2):419-26. 69. Tzvetanov I, Spaggiari M, Joseph J, Jeon H, Thielke J, Oberholzer J, Benedetti E. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature. Transplant Proc. 2012 Dec; 44(10):2971-5 70. Tzvetanov I, Spaggiari M, Jeon H, Garcia-Roca R, Osipova M, Oberholzer J, Benedetti E. Renal artery aneurysm in robotic donor nephrectomy: a case report. Exp Clin Transplant. 2012 Jun; 10(3):293-5. Erratum in: Exp Clin Transplant. 2012 Aug; 10(4):418. 71. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012 Jul;143(1):88-98.e3
Page 17/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 72. Yerlioglu E, Krishnamoorthy V, Jeon H, Gustin A, Nicolau-Raducu R. Patentforamen ovale and intracardiac thrombus identified by transesophagealechocardiography during liver transplantation. J Cardiothorac Vasc Anesth. 2012Dec; 26(6):1069-73 73. Casadaban L, Parvinian A, Tzvetanov IG, Jeon H, Oberholzer J, Benedetti E, Bui JT, Gaba RC. Unconventional Extrahepatic Neovascularization After Transplant Hepatic Artery Thrombosis: A Case Report. Transplant Proc. 2013 Jul 29. doi:pii: S0041-1345(13) 74. Oberholzer J, Giulianotti P, Danielson KK, Spaggiari M, Bejarano-Pineda L, Bianco F, Tzvetanov I, Ayloo S, Jeon H, Garcia-Roca R, Thielke J, Tang I, Akkina S, Becker B, Kinzer K, Patel A, Benedetti E. Minimally invasive robotic kidney transplantation for obese patients previously denied access to transplantation. Am J Transplant. 2013 Mar; 13(3):721-8. 75. Choudhury N, Khan AB, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H. Cerebellar abscess caused by Listeria monocytogenes in a liver transplant patient. Transpl Infect Dis. 2013 Dec;15(6):E224-8. 76. Tzvetanov I, Giulianotti PC, Bejarano-Pineda L, Jeon H, Garcia-Roca R, Bianco F, Oberholzer J, Benedetti E. Robotic-assisted kidney transplantation. Surg Clin North Am. 2013 Dec;93(6):1309-23 77. Tzvetanov I, Bejarano-Pineda L, Giulianotti PC, Jeon H, Garcia-Roca R, Bianco F, Oberholzer J, Benedetti E. State of the art of robotic surgery in organ transplantation. World J Surg. 2013 Dec;37(12):2791-9. 78. Choudhury N, Khan AB, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H. Multiple Aspergillus Brain Abscesses after Liver Transplantation. Transplantation 2014 Jun 27;97(12):e72-e73 79. Tzvetanov I, D'Amico G, Walczak D, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E. High Rate of Unemployment After Kidney Transplantation: Analysis of the United Network for Organ Sharing Database. Transplant Proc. 2014 May 14. pii: S0041-1345(14)00121-32014 May 14. pii: S0041-1345(14)00121-3 80. Khan A, Park P, Oberholzer J, Tzvetanov I, Garcia Roca R, Gaba RC, Benedetti E, Jeon H. Concurrent hepatic artery and portal vein thrombosis after orthotopic liver transplantation with preserved allografts. Case Rep Transplant. 2014;2014:384295. 81. Naffouje SA, Tzvetanov, I, Bui JT, Gaba R, Bernardo K, Jeon H. Obesity increases the risk of primary nonfunction and early access loss, and decreases overall patency in patients who underwent Hemodialysis Reliable Outflow device placement. Ann Vasc Surg. 2016 Oct;36:236-243 82. Garcia-Roca R, Garcia-Aroz S, Tzvetanov I, Jeon H, Oberholzer J, Benedetti E. Single center experience with robotic kidney transplantation for recipients with BMI of 40kg/m2 or greater: A comparison with the UNOS registry. Transplantation. 2017 Jan;101(1):191-196. 83. Garcia-Roca R, Tzvetanov IG, Jeon H, Hetterman E, Oberholzer J, Benedetti E. Successful living donor intestinal transplantation in cross-match positive recipients: Initial experience. World J Gastrointest Surg. 2016 Jan 27;8(1):101-105
BOOK CHAPTERS AND MONOGRAPHS
Page 18/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 1. Reich DJ, Jeon H, Manzarbeitia CY : Complications in Hepatobiliary Surgery, in Complications in General Surgery, Nadey Hakim, Editor, Imperial Press, London, March 2007, ISBN-13: 978-1860946929 2. Jeon H, Ranjan D : Liver transplantation for hepatocellular carcinoma under MELD score-bases allocation system, in Liver Transplantation and Hepatocellolar Carcinoma, Cataldo Doria, Editor, International College of Surgeons, Chicago, November 2007 3. Jeon H, Ramaiah C, Ranjan D : Venous and lymphatic disorders in transplantation, in Venous and Lymphatic Diseases, Robert S. Dieter, editor, McGraw Hill, New York, January 2011, ISBN : 978-0-07-160158-9 4. Jeon H, Shin TH, Tzvetanov I, Benedetti E : Minimally invasive live donor hepatectomy, in Contemporary Liver Transplantation, Cataldo Doria, editor, Springer International Publishing Switzerland, February 2015, ISBN: 978-3-319-05543-5 5. Shin TH, Jeon H : Surgical treatment of cholangiocarcinoma, in Cholangiocarcinoma, Charles E. Ray et al. , editors, Nova Science Publishers, Inc., New York, 2015, ISBN: 978-162948-034-3
Page 19/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae PRESENTATIONS
Presented Abstracts at Regional, National, and International Meetings 1. Lee YJ, Lee SG, Park KM, Jeon H, Hwang S, Min PC: A case report of localized sclerosing cholangitis in common hepatic duct. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997 2. Lee YJ, Lee SG, Park KM, Jeon H, Hwang S, Min PC: Hepatopancreatoduodenectomy for the advanced biliary carcinomas. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997 3. Jeon H, Hwang S, Park KM, Lee YJ, Lee SG: Pancreatoduodenectomy or total pancreatectomy combined with vascular or adjacent organ resection in periampullary malignancy. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997 4. Lee YJ, Lee SG, Park KM, Jeon H, Hwang S, Min PC: Report of 2 cases of advanced mucin-secreting pancreatic tumor. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997 5. Jeon H, Nam CW, Park KM, Lee YJ, Lee SG, Min PC: Safety of Major hepatobiliary and pancreatic surgery in the elderly. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan 1997 6. Jeon H, Park KM, Lee YJ, Lee SG, Min PC: Single layer parachuted intussussepted pancreaticojejunostomy. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997 7. Yun IJ, Jeon H, Cho KS, Won KS, Ryu KW, Lee HS, Kim YB, Kim YI, Park RK, Lee DH: A case of methyl malonic academia treated with living related liver transplantation. International Congress of the Transplantation Society, Rome, Italy, September 2000 8. Yoshizumi T, Gondolesi GE, Jeon H, Schwartz ME, Shimada M, Miller CM, Emre S: An assessment of standard liver volume, description of a new formula. American Transplant Congress, Washington D.C., April 2002 9. Jeon H, Reich DJ, Kaul V, Braitman L, Nathan HM, Hasz RD, Ortiz JA, Araya VR, Rothstein KD, Munoz SJ, Manzarbeitia CY: Livers from morbidly obese donors: Results of 97 attempted procurement-Half provided transplants. International Liver Transplantation Society, Chicago, June 2002 10. Manzarbeitia CY, Reich DJ, Ortiz JA, Munoz SJ, Araya VR, Rothstein KD, Jeon H, Alvarez SC, Oleaga J, Horrow M : Non-surgical management of late hepatic artery stenosis after liver transplantation. International Liver Transplantation Society, Chicago, June 2002 11. Jeon H, Ortiz JA, Giraldo JC, Reich DJ, Manzarbeitia CY: Risk of deep vein thrombosis associated with venovenous bypass for liver transplantation. International Liver Transplantation Society, Chicago, June 2002 12. Ranjan D, Johston TD, Jeon H, Rogers C, Blair F: Comparative financial analysis of liver transplantation in the pre and post MELD era. American Transplant Congress, Washington D.C., June 2004 13. Ranjan D, Chen C, Jeon H, Johston TD: Curcumin inhibit mixed lymphocyte reaction stiulated cell proliferation via inhibition of IL-2. American Transplant Congress, Washington D.C., June 2004 14. Cox M, Grantz D, Polly L, Jeon H, Ibrahim M, Johston TD, Ranjan D, “Effects of an Internal Task Force Fiscal Evaluation of a Liver Transplant Program” Presented at: UNOS Meeting Miami, Florida, May 2004
Page 20/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 15. Mozafarri F, Jeon H, Ibrahim M, Johston TD, Ranjan D. “Hepactic Artery Thrombosis after Adult Orthotopic Liver Transplantation: Spectrum of Complications.” Presented at: ICA Meeting 2004 Lexington, Kentucky, July 2004 16. Jeon H, Johston TD, Strup SE, Ibrahim M, Ranjan D : University of Kentucky experience of laparoscopic live donor nephrectomy using two different techniques.Presented at Annual Congress of International College of Surgeons. July 2004 Anchorage, Alaska 17. Bouneva I, Johston TD, Turner V, Schmonsky K, Jeon H, Ibrahim M, Ranjan D: Clinical and financial impact of obesity in liver transplantation in a rural area. American Association of Study of Liver Disease, Boston, October 2004 18. Schmonsky K, Turner V, Bouneva I, Ibrahim M, Jeon H, Johston TD, Ranjan D: Analysis of smoking in patients referred for liver transplantation and its adverse impact on short term outcomes. American Association of Study of Liver Disease, Boston, October 2004 Awarded Presentation 19. Bouneva I, Johston TD, Jeon H, Turner V, Ranjan D: “Clinical predictors of greater resource utilization in orthotopic liver transplantation”. Presented at: ATC Meeting, Seattle, Washington (May 2005) 20. Schmonsky K, Turner V, Bouneva I, Johston TD, Jeon H, Ibrahim M, and Ranjan D. "Financial Management of Potential Donor Management at a Medicare Approved Transplant Hospital." Presented at: American Transplant Congress, Seattle Washington (May 2005). 21. Bouneva I, Johnston TD, Jeon H, Turner V, Ranjan D. “Clinical predictors of greater resource utilization in orthotopic liver transplantation”. Presented at: Transplant Administrators Meeting Memphis, Tennessee (May 2005) 22. Schmonsky K., Turner V., Bouneva I., Johnston T., Jeon H., Ibrahim M., and Ranjan D. "Financial Management of Potential Donor Management at a Medicare Approved Transplant Hospital." Presented at: American Transplant Congress, Seattle Washington (May 2005). 23. Schmonsky K., Turner V., Bouneva I., Johnston T., Jeon H., Ibrahim M., and Ranjan D. "Financial Management of Potential Donor Management at a Medicare Approved Transplant Hospital." Presented at: Transplant Administrators Meeting Memphis, Tennessee (May 2005) 24. Kaur PJ, Johnston T., Jeon H., Ranjan D. “Whipple Pancreato-duodenectomy for arteriovenous malformation and gastrointestinal bleeding”. Presented at: AAS. San Diego, CA (2006) 25. Chen C., Johnston T., Jeon H, Shah S., Ranjan D. “CsA induced MDA formation in EBV infected and uninfected human B cells”. Presented at: Academic Surgical Congress. San Diego, CA (2006) 26. Chen C., Johnston T., Jeon H, Ranjan D. “CsA activates NFkB in EBV infected and uninfected human B cells”. Presented at: Academic Surgical Congress. San Diego, CA (2006) 27. Shah S., Johnston T., Jeon H, Ranjan D. “Effect of Chronic Glucocorticoid Therapy and the Gender Difference on Bone Transplant Patients”. Presented at: Academic Surgical Congress. San Diego, CA (2006) 28. Mozaferri F., Jeon H, Johnston T., Ranjan D. “Dacron Graft for Vena Cava Replacement during Liver Transplantation.” Presented at: Academic Surgical Congress. San Diego, CA (2006)
Page 21/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 29. Clifford T, Johnston T, Jeon H, Ranjan D. “A Pharmacoeconomic Analysis of Liver Transplant Charges at a Single Institution Over 11 Years.” Presented at: UNOS Transplant Management Forum. San Francisco, CA (2006) 30. Johnston T,. Jeon H, Gedaly R, Ranjan D. A Meta-Analysis of the Impact of Multiple arteries in Allografts Procured by Laparoscopic Nephrectomy, Presented at the American Society of Nephrology Meeting in San Diego, (Nov 2006). 31. Johnston T, Gedaly R, Jeon H, Ranjan D. Are multiple arteries a contraindication for living donor kidney transplant? Presented at the American Transplant Society Meeting Held in Marco Island, Florida, (January 2007). 32. Johnston T, Gedaly R, Jeon H, Ranjan D. Obesity and Renal Transplant graft Survival: A Meta-Analysis. Presented at the Association of Academic Surgeons, Phoenix, AZ , (February 2007). 33. Johnston T, Gedaly R, Jeon H, Ranjan D. The risk of graft failure in laparoscopically procured kidneys having multiple renal arteries in less than the risk with deceased donor kidneys. Presented at the Association of Academic Surgeons, Phoenix, AZ , (February 2007) 34. Ranjan D, Johnston TD, Jeon H, Gedaly R. Liver transplant subsequent care revenue: impact of Critical Care. ICS. Reno, NV (June 2007) 35. Johnston T, Gedaly R, Jeon H, Ranjan D. Outcomes with Non-Heart Beating Liver Donors: A Meta-Analysis. University of Kentucky, Transplant Division. Presented at the European Society of Organ Transplantation in Prague, Czech Republic (September 2007). 36. Gedaly R, Gilbert J, Jeon H, Koch A, Ranjan D. Predictors of Survival in Patients with Hepatocellular Carcinoma after Transplantation. University of Kentucky, Transplant Division. Presented at the European Society of Organ Transplantation in Prague, Czech Republic (September 2007). 37. Johnston T, Gedaly R, Jeon H, Ranjan D. Impact of Obesity in Liver Transplant Outcomes: Not a Simple Answer. University of Kentucky, Transplant Division. ASTS winter Symposium, Marco Island FL, (January 2008). 38. Jeon H, McHugh PP, Johnston TD, Gedaly R, Ranjan D. Management of hepatic artery pseudoaneurysm after liver transplantation. IHPBA Mumbai, India, (March 2008) 39. Jeon H, McHugh PP, Johnston TD, Gedaly R, Ranjan D. Comparison of pancreas transplantation outcome by drainage type. IHPBA Mumbai, India, (March 2008) 40. Jeon H, McHugh PP, Clifford TM, Johnston TD, Gedaly R, Ranjan D. Basiliximab induction in orthotopic liver transplant recipients for delayed tacrolimus initiation and renal protection. IHPBA Mumbai, India, (March 2008) 41. Gedaly R, Gilbert J, Johnston TD, Jeon H, Shokouh-Amiri H, Vera S Koch A, Ranjan D. Tumor size ; The best and most powerful surrogate of vascular invasion. ILTS Paris, France, (July 2008) 42. Bhati C, Tzvetanov I, Oberholzer J, Benedetti E, Jeon H ; Standard liver volume in morbidly obese individuals without medical illness. American Transplant Congress. San Diego, (May 2010) 43. Campara M, Jeon H, Tzvetanov I, Oberholzer J, Benedetti E, Tang I ; Renal allograft outcome in combined liver-kidney transplant on calcineurin inhibitor vs. CNI and mycophenolate maintenance immunesuppression. American Transplant Congress. San Diego, (May 2010)
Page 22/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 44. Giulianotti PC, Oberholzer J, Tzvetanov I, Jeon H, Bhati C, Benedetti E ; Fully robotic kidney transplantation in morbidly obese recipients: Initial experience. American Transplant Congress. San Diego, (May 2010) 45. Tzvetanov I, Oberholzer J, Jeon H, Kinzer K, Benedetti E. “Robot-Assisted Live Donor Nephrectomies at the University of Illinois at Chicago” Oral Presentation, Clinical Robotic Surgical Association, 2nd Worldwide Congress, Chicago, IL, (September 2010). 46. Kinzer K, Tzvetanov I, Jeon H, Gorodner V, Galvani C, Horgan S, Benedetti E, Oberholzer J ; Robotic assisted live donor nephrectomy : Ten year institutional report and analysis. American Transplant Congress. Philadelphia, (May 2011) 47. Tzvetanov I, Spaggiari M, Jeon H, Garcia-Roca R, Campara M, Thielke J, Oberholzer J, Benedetti E : Simultaneous ABO Incompatibility and Positive Cross-Match in Kidney Transplantation: Our Experience and Review of Literature. American Transplant Congress, Boston, MA. (June 2012). Awarded Presentation 48. Tzvetanov I, Oberholzer J, Spaggiari M, Jeon H, Garcia-Roca R, Campara M, Thielke J, Giulianotti PC, Benedetti E : Robotic Kidney Transplantation in Obese Recipients: Preliminary Experience. American Transplant Congress, Boston, MA. (June 2012). Oral Presentation 49. Spaggiari M, Tzvetanov I, Setty S, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E : Spleen Cell Populations Involved in Antibody Mediated Rejection after Kidney Transplantation: Pathological and Clinical Findings. American Transplant Congress, Boston, MA. (June 2012). 50. Bhati C, Parikh K, Danielson K, Tzvetanov I, Oberholzer J, Benedetti E, Jeon H : Estimated Measurement of Standard Liver Volume in Highly Obese Individuals without Medical Illness. American Transplant Congress, Boston, MA. (June 2012). 51. Garcia-Roca R, Choudhury N, Tzvetanov I, Jeon H, Oberholzer J, Benedetti E Understanding Racial Disparity in Living Donor Kidney Transplantation. American Transplant Congress, Boston, MA. (June 2012). 52. Tzvetanov I, Bejarano-Pineda L, Setty S, Harbhajanka A, Khan A, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E. The Association of B Cell Population in Splenic Histology of ABO Incompatible Kidney Transplantation and One-Year Graft and Recipient Survival. American Transplant Congress, Seattle, WA, (May 2013). 53. Bhati C, Khan A, Garcia-Roca R, Tzvetanov I, Oberholzer J, Benedetti , Jeon H: Liver Transplantation in Patients Older Than 70 Years: Call of Caution. World Transplant Congress, San Francisco, CA (July 2014). 54. Jeon H, Hyoung H., Park P, Khan A, Bhati C, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E: A Single U.S. Center Experience of Orthotopic Liver Transplantation in Patients With MELD Score Greater than 35. World Transplant Congress, San Francisco, CA (July 2014). 55. Khan A, Hughes D, Bhatti C, Tzvetanov I, Garcia-Roca R, Akkina S, Oberholzer J, Benedetti E, Jeon H: A Single-Center, Retrospective Evaluation of Outcomes Following Cross Match Positive Simultaneous Liver Kidney Transplantation. World Transplant Congress, San Francisco, CA (July 2014). 56. Tzvetanov I, D’Amico G, Giulianotti P.C., Jeon H Garcia-Roca R, Oberholzer J, Benedetti E: Superior Two-year Graft Survival After Robotic Kidney Transplantation in Obese Recipients: Does Wound Infection Really Matter? World Transplant Congress, San Francisco. CA (July 2014).
Page 23/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 57. Garcia-Roca R, Williams T, D’Amico G, Tzvetanov I, Jeon H, Giulianotti P.C., Bianco F, Oberholzer J, Benedetti E: Robotic Kidney Transplant in Morbid Obesity. World Transplant Congress, San Francisco, CA (July 2014) 58. Garcia-Roca R, D’Amico G, Williams T, Tzvetanov I, Jeon H, Giulianotti P.C., Bianco F, Oberholzer J, Benedetti E: One Hundred-four Robotic Kidney Transplant. World Transplant Congress, San Francisco, CA (July 2014) 59. Tzvetanov I, D’Amico G, Walczak D, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E:high Rate of Unemployment After Kidney Transplantation: Analysis of the UNOS Database. World Transplant Congress, San Francisco, CA (July 2014) 60. Campara M, Tzvetanov I, Giulianotti P.C., Khan A, Garcia-Roca R, Jeon H, Holterman M, John E, Benedetti E: Living Donor Parathyroid Allotransplantation. World Transplant Congress, San Francisco, CA (July 2014) 61. Han H, Khan A, Park P, Bhati C, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H: Single center retrospective evaluation of the survival differences as per discharge disposition of OLT patients with high MELD score. World Transplant Congress, San Francisco, CA (July 2014) 62. Tzvetanov I, D'Amico G, Georgiev G, Jeon H, Garcia-Roca R, Benedetti E, Oberholzer J. Combined Robotic Kidney Transplantation and Sleeve Gastrectomy in Obese Recipients: Initial Results from Prospective Randomized Study. American Transplant Congress, Philadelphia, PA (May 2015) 63. Tzvetanov I, D'AmicoG, Georgiev G, Giulianotti P, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E. Robotic Kidney Transplantation in Obese Recipients Can Lead to Superior Outcomes in Terms of Wound Infection and Graft Survival. American Transplant Congress, Philadelphia, PA (May 2015) 64. Garcia Roca R, Martinez Parra C, Tzvetanov I, Jeon H, Benedetti E, Oberholzer J. Application of the Clavien Classification of Surgical Complications to Robotic Kidney Transplantation. American Transplant Congress, Philadelphia, PA (May 2015) 65. Bhati C, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H. U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors. American Transplant Congress, Philadelphia, PA (May 2015)
INVITED LECTURESHIPS 10.22.2014 Transplant Symposium: Mininally invasive donor hepatectomy. Medical College of Wisconsin, Milwaukee, WI 04.25.2014 Surgical Grand Round: Recent Advances of Solid Organ Transplantation. Mount Sinai Medical Center, Chicago, IL 03.26.2014 Expanded criteria liver donors other than DCD (Panel Presentation and Discussion) Clinical Congress, International Pancreatohepatobiliary Association (03.22.2014 – 3.27.2014), Seoul, Korea
02.13.2014 Liver transplantation in 2014 Medical Grand Round, Advocate Christ Medical Center, Oak Lawn, IL
Page 24/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 11.17.2012 Liver transplantation in minorities, Bridging the gap symposium, University of Illinois at Chicago, Chicago, IL 11.01.2012 Living kidney donation – What is really like. National Kidney Foundation of Illinois, Chicago, IL 10.05.2012 The Current Status of Living Donor Liver Transplantation in the Far East: Japan, Korea, and Hong Kong. 6th International Conference “Living Donor Abdominal Organ Transplantation: State of the Art”, Bari, Italy
03.12.2012 Living with kidney transplantation. National Kidney Foundation of Illinois, Chicago, IL 11.04.2011 Barriers in renal transplantation. Multidisciplinary Conference, American Kidney Foundation, Oakbrook, IL 10.26.2011 Current management of colorectal liver metastasis Bridging the gap symposium – Emerging Health Issues in Underrepresented Minorities, Chicago, IL
10.13.2011 Surgical Grand Round: Liver transplantation in 2011. Mount Sinai Medical Center, Chicago, IL 09.27.2011 Donation after cardiac death (Panel Presentation and Discussion) Clilnical Congress of Asian Society of Transplantation , Seoul, Korea 05.14.2011 Training and education in clinical transplantation. (Panel Presentation and Discussion) Academic Congress, Korean Medical Association, Seoul, Korea 11.21.2010 Organ Recovery symposium: Logistics and Technique of Multiorgan Recovery. Korean Organ Donation Agency, Seoul, Korea
12.03.2009 Medical Grand Round: Hepatocellular carcinoma. Advocate Christ Medical Center, Chicago, IL
02.21.2008 Transplant Teaching Conference: Living donor liver transplantation between adults – East Asian Experience. Virginia Commonwealth University, Richmond, VA
10.04.2007 7TH Annual CEU Roundtable Conference for Health Care Professionals, Professional Healthcare Institute of America, Louisville, KY 09.11.2007 Kentucky Organ Donor Affiliates Board Meeting: Using extended criteria donors through a successful working relationship between OPO‘s and transplant programs, Lexington, KY
07.27.2007 Surgical Grand Round: Liver Transplantation – Update 2007, College of Medicine, Korea University, Seoul, Korea
Page 25/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 07.26.2007 ICU Lecture Series: Management of organ donors. Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea 07.20.2007 Visiting Professorship, 1st International Transplant Symposium: Liver transplantation for hepatitis C. Transplant Research Center, Konkuk University, Seoul, Korea 07.18.2007 Surgical Grand Round: Use of marginal donor organs in liver transplantation. College of Medicine, University of Ulsan, Seoul, Korea 08.05.2005 Surgical Grand Round: Liver Transplantation for Hepatocellular Carcinoma. College of Medicine, Seoul National University, Seoul, Korea 03.18.2004 What’s hot and new in solid organ transplantation Korean Bioscientist Association in Lexington, Kentucky 03.24.2000 Surgical Grand Round: Living related liver transplantation. Korea University College of Medicine, Seoul, Korea 05.11.2000 Inaugural Conference of Korean Society of Hereditary Metabolic Disorders: Role of liver transplantation for inborn errors of metabolism. Seoul, Korea 11.07.1999 Transplant Grand Round: Initial experience of living-donor liver transplantation in Korea. Gottingen University, Gottingen, Germany
Page 26/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae EDUCATIONAL ACTIVITIES Departmental & Medical School Presentations University of Illinois at Chicago
05.27.2009 Surgical Grand Round: Partial liver transplantation – Technical Challenges and their solutions.
2010– 2017 Surgery Resident Teaching Conferences: Transplantation
2010 – 2017 Surgery Resident Teaching Conferences: Hepatic Tumors
07.07.2010 Family Medicine Grand Round: Long-term management after transplantation by a primary care physician.
2011- 2017 Surgery Resident Teaching Conferences: Surgical Anatomy of Liver, Benign hepatic tumor, Transplantation
2011-2017 Gastroenterology Fellow Core Lecture: Liver Transplantation
Previous Institutions
2005 - 2008 “Hepatobiliary system” for ABSITE review Department of Surgery, University of Kentucky
11.16.2006 “Introduction to solid organ transplantation” Ward O. Griffen Surgical Society College of Medicine, University of Kentucky
02.22.2005 Liver Transplant –Update 2005 : “What Radiologists Needs to Know” lecture series: Department of Radiology, College of Medicine, University of Kentucky: Lexington, Kentucky
2005 - 2009 General Surgery Resident Conference: “Liver Surgery”. College of Medicine, University of Kentucky, Lexington, Kentucky
11.10.2004 Surgical GrandRound: Partial liver transplantation – Technical Challenges and their solutions. College of Medicine, University of Kentucky, Lexington, Kentucky
10.16.2002 Use of marginal donor organs for transplantation. Department of Surgery, Albert Einstein Medical Center, Jefferson Medical College, Philadelphia, Pennsylvania
Page 27/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae 10.30.2001 Medical Grand Round, Living donor liver transplantation. Department of Medicine, Albert Einstein Medical Center, Jefferson Medical College, Philadelphia, Pennsylvania
05.12.1998 Surgical Grand Round: Nutritional support of surgical patient. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Medical School Courses Prepared & Taught University of Illinois at Chicago Course Co-director: Radiology – Surgery – Anatomy Combined elective: October 2014 – 2016 (An elective course for 4th year medical students for 12 weeks – 4 weeks for each of three groups)
Lecturer: Medical Pharmacology: Immune suppressive medications for 2nd year medical students: October 2012 to May 2013.
Course Co-director: Transplantation Physiology: September 2010 to 2016 (A part of “Introduction to patient care” program) a ten-week lecture course given as an elective for second year medical students, offered in both fall and spring semesters every year since Fall 2010 to present
Preceptor for 2nd year medical students: Essentials of Clinical Medicine: Abdominal examination. May 2009 to 2016.
Lecturer and preceptor for 3rd year medical students: General Surgery Core Clerkship: May 2009 to 2016. Acute abdomen, Stress response to trauma and surgery, transplantation, clinical simulation
Course coordinator and preceptor for 4th year medical students: Transplant Surgery Clerkship (Elective): May 2009 to 2016. ELEC 677
History of Modern Surgery: Organ Transplantation: The Honors College: Course Hon 201: October 2009
Previous Institutions “Introduction to Solid Organ Transplantation”, a twelve-week lecture course given as an elective for first and second year medical students at University of Kentucky, offered in both fall and spring semesters every year since Fall 2004 to Spring 2009. SUR 815-004 University of Kentucky
Preceptor for 3rd year medical students: Clinical Clerkship: Course MD 815: September 2003 to April 2009. University of Kentucky
Preceptor for 4th year medical students: Acting Internship: Course MD 815: September 2003 to April 2009. University of Kentucky
Page 28/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae
Preceptor for 1st year medical students: Patient Centered Medicine: Course MD 815: November 2006 to May 2007. University of Kentucky
Preceptor, “Surgical anatomy of abdomen”, a six-hour combined lecture and cadaver dissection course offered as an elective for first year medical student at Mount Sinai School of Medicine, April, 2001. University of Kentucky
“Management of end-stage liver disease”, A two-hour lecture as a part of Gastroenterology lecture series for third year medical student at Soonchunhyang University College of Medicine. given in fall semester yearly 1998-1999
“Surgical Disease of Pancreas”, A four-hour lecture as a part of Gastroenterology lecture series for third year medical student at Soonchunhyang University College of Medicine. given in fall semester yearly 1998-1999
Coordinator, “Surgery – Radiology – Pathology conference” Soonchunhyang University College of Medicine. Biweekly 1998-1999
Continuing Medical Education CCTN Certification course, University of Illinois at Chicago, September 2010
Living donor liver transplantation in Chicago 2010. Walter Payton Liver Symposium, University of Illinois at Chicago, September 2010
Multidisciplinary managements of malignant tumor of the liver. Walter Payton Liver Symposium, University of Illinois at Chicago, September 2009
New liver allocation algorithm and its impact on our patient care – The sicker first. Transplant Update Issue 2. March 2005
“Liver transplantation for liver cancers”. Transplant Update Issue 1. Oct. 2004
Editor, “Transplant Update”. A quarterly newsletter from UK Transplant Center to referral physicians (primary care physicians, nephrologists, and gastroenterologists in Kentucky and West Virginia)
Post-graduate training Transplant Surgery Fellows Name Date Current Position Chandra Bhati, MD 7.2009 – 6.2011 Transplant Surgeon, Virginia Commonwealth University, Richmond, VA Atul Nanda, MD 7.2011 – 6.2012 General surgeon, Norwegian American Medical Center, Chicago, IL Arshad Khan, MD 10.2011 – 9.2013 Transplant Surgeon, University of Illinois at Chicago, Chicago, IL
Page 29/30 3/1/17 Hoonbae Jeon, M.D. Curriculum Vitae
INSTITUTIONAL SERVICE Specialty career advisor in general surgery, Office of Student Affairs, College of Medicine, University of Illinois at Chicago, September 2011 - 2016
Admission interviewer, College of Medicine, University of Illinois at Chicago, April 2010 – Apr 2013
Admission interviewer, General Surgery Residency Program, University of Illinois at Chicago, September 2010 – 2016
Team-based faculty academic advisor, College of Medicine, University of Illinois at Chicago, September 2012 – 2015 mentored seven medical students in class of 2016 : Angelica Alonso Matthew Gust Wentao Li Garrett Schwarzman Meera Thakkar Eric Yoo Brittany Smith
Fellow, The Honors College, University of Illinois at Chicago, March 2010 – 2016 84. Garcia-Roca R, Tzvetanov IG, Jeon H, Hetterman E, Oberholzer J, Benedetti E.
Faculty academic advisor, College of Medicine, University of Illinois at Chicago Previous Advisees: Eric Kirshenbaum, MD 2009-2013, Resident in Urology, Loyola University Stacy J. Kim, MD 2009-2013, Resident in Radiology, Saint Louis University
COMMUNITY AND SOCIAL SERVICE Board Member, Lexington Korean School: July 2004 – 2010
Advisory Board Member, Korean American Community Services, Community Health programs (4300 N. California Ave.,Chicago, IL 60618): December 2009 – 2013
Executive Board Member: Korean American Community Services (4300 N. California Ave.,Chicago, IL 60618): July 2010 – 2014
Advisory Board Member, Asian Health Coalitions of Illinois: July 2010 – 2012 (180 W. Washington Street, Suite 1000, Chicago, IL 60602 )
Medical Advisory Board Member, American Liver Foundation Great Lakes Division, April 2010 - 2017
Page 30/30 3/1/17